Prognostic potentials of miRNA-19a-3p and PDCD5 in nasopharynx carcinoma
- PMID: 33215428
- DOI: 10.26355/eurrev_202011_23598
Prognostic potentials of miRNA-19a-3p and PDCD5 in nasopharynx carcinoma
Abstract
Objective: To determine expressions of MicroRNA-19a-3p (miRNA-19a-3p) and PDCD5 in nasopharyngeal carcinoma (NPC) tissues, and their prognostic potentials in NPC.
Patients and methods: Expressions of miRNA-19a-3p and PDCD5 in NPC tissues and controls were determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The correlation between expressions of miRNA-19a-3p and PDCD5 in NPC was evaluated by Pearson correlation test. Furthermore, potential influences of miRNA-19a-3p and PDCD5 on clinical features of NPC patients were assessed. Through 5-year follow-up, survival analysis in NPC patients was conducted by Kaplan-Meier method. Finally, factors influencing prognosis of NPC were determined using the Cox regression model.
Results: MiRNA-19a-3p was upregulated and PDCD5 was downregulated in NPC tissues. Pearson correlation test uncovered a negative correlation between expression levels of miRNA-19a-3p and PDCD5 in NPC tissues. MiRNA-19a-3p level was correlated with N classification and clinical stage in NPC patients, while PDCD5 level was correlated with T classification, pathological grade and clinical stage. Survival analysis showed poor prognosis in NPC patients expressing high level of miRNA-19a-3p or low level of PDCD5. Cox regression analysis illustrated that N2+3 classification, clinical stage III+IV, high level of miRNA-19a-3p and low level of PDCD5 were independent risk factors for the prognosis of NPC.
Conclusions: MiRNA-19a-3p is upregulated and PDCD5 is downregulated in NPC tissues. High level of miRNA-19a-3p and low level of PDCD5 are unfavorable for the prognosis of NPC.
Similar articles
-
Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.Cell Physiol Biochem. 2018;46(6):2215-2231. doi: 10.1159/000489590. Epub 2018 May 3. Cell Physiol Biochem. 2018. PMID: 29734189
-
Downregulation of miRNA-429 and upregulation of SOX2 were unfavorable to the prognosis of nasopharyngeal carcinoma.Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8402-8407. doi: 10.26355/eurrev_202008_22637. Eur Rev Med Pharmacol Sci. 2020. PMID: 32894547
-
Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.Cancer Med. 2020 Feb;9(3):1230-1241. doi: 10.1002/cam4.2676. Epub 2019 Dec 19. Cancer Med. 2020. PMID: 31856390 Free PMC article.
-
Diagnostic and prognostic values of KLK11 in nasopharyngeal carcinoma.Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9423-9428. doi: 10.26355/eurrev_202009_23027. Eur Rev Med Pharmacol Sci. 2020. PMID: 33015784
-
LncRNA SNHG15 promotes the proliferation of nasopharyngeal carcinoma via sponging miR-141-3p to upregulate KLF9.Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6744-6751. doi: 10.26355/eurrev_202006_21662. Eur Rev Med Pharmacol Sci. 2020. PMID: 32633365
Cited by
-
Analysis of the regulatory mechanisms of prognostic immune factors in thyroid cancer.Front Oncol. 2022 Dec 14;12:1059591. doi: 10.3389/fonc.2022.1059591. eCollection 2022. Front Oncol. 2022. PMID: 36591507 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
